Screener
Regeneron Pharmaceuticals REGN Total costs & expenses
Total costs & expenses at other companies
Other financials
Where this comes from
Reported directly by Regeneron Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:CostsAndExpenses.
The source filing: Regeneron Pharmaceuticals’s 10-Q, filed July 30, 2026.
- Filed
- Jul 30, 2026, 6:52 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000872589-26-000025
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Selling, general, and administrative | 662.1 | 634.2 | 1,309.8 | 1,267.2 |
| Cost of goods sold | 360.7 | 275.6 | 734.1 | 541.1 |
| Cost of collaboration and contract manufacturing | 215.8 | 254.6 | 511.8 | 453.4 |
| 2,997.2 | 2,596.1 | 5,959.7 | 5,033.1 | |
| Income from operations | 1,293.5 | 1,079.5 | 1,936.4 | 1,671.2 |
| Other income (expense): | ||||
| Other income (expense), net | 245.3 | 442.8 | 446.5 | 764.8 |
| Interest expense | (11.0) | (3.6) | (23.9) | (12.3) |
Item 1. Financial Statements (unaudited)
FAQ
- What is Regeneron Pharmaceuticals's total costs & expenses?
- Regeneron Pharmaceuticals (REGN) reported total costs & expenses of $3B in Q2 2026.
- How has Regeneron Pharmaceuticals's total costs & expenses changed year-over-year?
- Regeneron Pharmaceuticals's total costs & expenses increased by 15.5% year-over-year, from $2.6B to $3B.
- What is the long-term trend for Regeneron Pharmaceuticals's total costs & expenses?
- Over 4 years (2021 to 2025), Regeneron Pharmaceuticals's total costs & expenses has grown at a 10.9% compound annual growth rate (CAGR), from $7.12B to $10.77B.
- What does total costs & expenses mean?
- This metric aggregates all operating costs incurred by the company to generate revenue, including cost of goods sold, research and development, and selling, general, and administrative expenses. It serves as a comprehensive measure of the company's total operational footprint and cost structure. Analyzing this figure helps investors evaluate the company's ability to manage its cost base relative to its top-line growth.
Ask your AI about Regeneron Pharmaceuticals's total costs & expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude